Eikon Therapeutics, Inc.
EIKN
$8.77
-$0.21-2.34%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Net Income | -21.56% | -22.69% | |||
| Total Depreciation and Amortization | -20.92% | -17.86% | |||
| Total Amortization of Deferred Charges | -- | -- | |||
| Total Other Non-Cash Items | 12.33% | 83.89% | |||
| Change in Net Operating Assets | -351.92% | -10.85% | |||
| Cash from Operations | -64.71% | -75.75% | |||
| Capital Expenditure | 98.83% | 99.83% | |||
| Sale of Property, Plant, and Equipment | -- | -- | |||
| Cash Acquisitions | -- | -- | |||
| Divestitures | -- | -- | |||
| Other Investing Activities | -5.98% | -14.46% | |||
| Cash from Investing | 4.97% | 399.33% | |||
| Total Debt Issued | -- | -- | |||
| Total Debt Repaid | -- | -- | |||
| Issuance of Common Stock | 1,663,271.43% | 1,046.32% | |||
| Repurchase of Common Stock | -- | -- | |||
| Issuance of Preferred Stock | -- | -- | |||
| Repurchase of Preferred Stock | -- | -- | |||
| Total Dividends Paid | -- | -- | |||
| Other Financing Activities | -- | -- | |||
| Cash from Financing | -0.26% | 1,046.32% | |||
| Foreign Exchange rate Adjustments | -- | -- | |||
| Miscellaneous Cash Flow Adjustments | -- | -- | |||
| Net Change in Cash | -31.24% | 100.48% | |||